AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 102 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $946,000 | +43.3% | 53,742 | -1.0% | 0.02% | +46.2% |
| Q1 2016 | $660,000 | -43.0% | 54,296 | +14.3% | 0.01% | -43.5% |
| Q4 2015 | $1,157,000 | +38.7% | 47,509 | +1.0% | 0.02% | +35.3% |
| Q3 2015 | $834,000 | -23.9% | 47,031 | -24.3% | 0.02% | -15.0% |
| Q2 2015 | $1,096,000 | -43.9% | 62,122 | -0.4% | 0.02% | -41.2% |
| Q1 2015 | $1,955,000 | +26.0% | 62,379 | +17.3% | 0.03% | +17.2% |
| Q4 2014 | $1,552,000 | +338.4% | 53,181 | +210.7% | 0.03% | +314.3% |
| Q3 2014 | $354,000 | – | 17,115 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |